FR2317917A1 - Melanges de l-aminoacides et leur utilisation therapeutique - Google Patents
Melanges de l-aminoacides et leur utilisation therapeutiqueInfo
- Publication number
- FR2317917A1 FR2317917A1 FR7620326A FR7620326A FR2317917A1 FR 2317917 A1 FR2317917 A1 FR 2317917A1 FR 7620326 A FR7620326 A FR 7620326A FR 7620326 A FR7620326 A FR 7620326A FR 2317917 A1 FR2317917 A1 FR 2317917A1
- Authority
- FR
- France
- Prior art keywords
- nitrogen
- amino acid
- oral
- parenteral
- essential
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001413 amino acids Chemical class 0.000 title abstract 4
- 150000008575 L-amino acids Chemical class 0.000 title abstract 3
- 229940024606 amino acid Drugs 0.000 abstract 3
- 235000001014 amino acid Nutrition 0.000 abstract 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 abstract 2
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 abstract 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 2
- 229930195722 L-methionine Natural products 0.000 abstract 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 2
- 229960004452 methionine Drugs 0.000 abstract 2
- 230000000050 nutritive effect Effects 0.000 abstract 2
- 235000018102 proteins Nutrition 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 abstract 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 abstract 1
- 239000004471 Glycine Substances 0.000 abstract 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 abstract 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract 1
- 229930064664 L-arginine Natural products 0.000 abstract 1
- 235000014852 L-arginine Nutrition 0.000 abstract 1
- 239000004201 L-cysteine Substances 0.000 abstract 1
- 235000013878 L-cysteine Nutrition 0.000 abstract 1
- IFQSXNOEEPCSLW-DKWTVANSSA-N L-cysteine hydrochloride Chemical compound Cl.SC[C@H](N)C(O)=O IFQSXNOEEPCSLW-DKWTVANSSA-N 0.000 abstract 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract 1
- 229930182844 L-isoleucine Natural products 0.000 abstract 1
- 239000004395 L-leucine Substances 0.000 abstract 1
- 235000019454 L-leucine Nutrition 0.000 abstract 1
- 229930182821 L-proline Natural products 0.000 abstract 1
- 239000004473 Threonine Substances 0.000 abstract 1
- LSPRRVXEZHYPEQ-WCCKRBBISA-N [N].CC(C)[C@H](N)C(O)=O Chemical compound [N].CC(C)[C@H](N)C(O)=O LSPRRVXEZHYPEQ-WCCKRBBISA-N 0.000 abstract 1
- UHAPMVGBCXHHJJ-JEDNCBNOSA-N [N].NCCCC[C@H](N)C(O)=O Chemical compound [N].NCCCC[C@H](N)C(O)=O UHAPMVGBCXHHJJ-JEDNCBNOSA-N 0.000 abstract 1
- PJBKTUCYYFCDPP-JEDNCBNOSA-N [N].N[C@@H](CC(C)C)C(=O)O Chemical compound [N].N[C@@H](CC(C)C)C(=O)O PJBKTUCYYFCDPP-JEDNCBNOSA-N 0.000 abstract 1
- UYDIZCSSXVBGRX-FVGYRXGTSA-N [N].N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O Chemical compound [N].N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O UYDIZCSSXVBGRX-FVGYRXGTSA-N 0.000 abstract 1
- XVHGMKLPKYSGHJ-FHAQVOQBSA-N [N].N[C@@H]([C@@H](C)CC)C(=O)O Chemical compound [N].N[C@@H]([C@@H](C)CC)C(=O)O XVHGMKLPKYSGHJ-FHAQVOQBSA-N 0.000 abstract 1
- AYVVCGWBBPFEPM-MUWMCQJSSA-N [N].N[C@@H]([C@H](O)C)C(=O)O Chemical compound [N].N[C@@H]([C@H](O)C)C(=O)O AYVVCGWBBPFEPM-MUWMCQJSSA-N 0.000 abstract 1
- KEZJTQKEIZISEP-QRPNPIFTSA-N [N].OC(=O)[C@@H](N)CC1=CC=CC=C1 Chemical compound [N].OC(=O)[C@@H](N)CC1=CC=CC=C1 KEZJTQKEIZISEP-QRPNPIFTSA-N 0.000 abstract 1
- MIHNXDNJLIYDMN-MMALYQPHSA-N [N].OC(=O)[C@@H](N)CSSC[C@H](N)C(O)=O Chemical compound [N].OC(=O)[C@@H](N)CSSC[C@H](N)C(O)=O MIHNXDNJLIYDMN-MMALYQPHSA-N 0.000 abstract 1
- 229960003767 alanine Drugs 0.000 abstract 1
- 229960002433 cysteine Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229960002885 histidine Drugs 0.000 abstract 1
- 238000001802 infusion Methods 0.000 abstract 1
- 229960000310 isoleucine Drugs 0.000 abstract 1
- 208000017169 kidney disease Diseases 0.000 abstract 1
- 229960003136 leucine Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 235000021542 oral nutrition Nutrition 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 235000016236 parenteral nutrition Nutrition 0.000 abstract 1
- 229960002429 proline Drugs 0.000 abstract 1
- 229960001153 serine Drugs 0.000 abstract 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 abstract 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 abstract 1
- 229960002898 threonine Drugs 0.000 abstract 1
- 229960004441 tyrosine Drugs 0.000 abstract 1
- 229960004295 valine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19752531204 DE2531204C2 (de) | 1975-07-12 | 1975-07-12 | L-Aminosäuregemische für die parenterale oder orale Ernährung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2317917A1 true FR2317917A1 (fr) | 1977-02-11 |
| FR2317917B1 FR2317917B1 (enrdf_load_stackoverflow) | 1979-05-18 |
Family
ID=5951356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7620326A Granted FR2317917A1 (fr) | 1975-07-12 | 1976-07-02 | Melanges de l-aminoacides et leur utilisation therapeutique |
Country Status (2)
| Country | Link |
|---|---|
| DE (1) | DE2531204C2 (enrdf_load_stackoverflow) |
| FR (1) | FR2317917A1 (enrdf_load_stackoverflow) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2935709A1 (de) * | 1978-09-04 | 1980-03-13 | Otsuka Pharma Co Ltd | Aminosaeureloesungen und deren verwendung |
| FR2711529A1 (fr) * | 1993-10-28 | 1995-05-05 | Clintec Nutrition Cy | Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme. |
| WO2003013487A3 (en) * | 2001-08-08 | 2003-05-30 | Professional Dietetics Srl | Amino-acid-based compositions, suitable in therapy for the healing and/or mending of wounds and lesions, in particular for application in the ophthalmic field |
| EP1044017A4 (en) * | 1998-01-05 | 2005-01-05 | Univ Johns Hopkins | DIETETIC SUPPLEMENT FOR PATIENTS DIALYSIS |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2946563C2 (de) * | 1979-11-17 | 1987-04-30 | B. Braun Melsungen Ag, 3508 Melsungen | Aminosäurelösung zur parenteralen Infusion |
| DE3821043A1 (de) * | 1988-06-22 | 1989-12-28 | Fresenius Ag | Dialysier- und spuel-loesung zur intraperitonealen verabreichung |
| IT1289754B1 (it) * | 1996-12-16 | 1998-10-16 | Professional Dietetics Srl | Composizioni a base di aminoacidi |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2260189A1 (de) * | 1971-12-09 | 1973-06-20 | Hossein Ghadimi | Injizierbare aminosaeurepraeparate |
| FR2215212A1 (enrdf_load_stackoverflow) * | 1973-01-18 | 1974-08-23 | Seperic |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2530246A1 (de) * | 1975-07-07 | 1977-01-13 | Fresenius Chem Pharm Ind | L-aminosaeuregemische fuer parenterale oder orale anwendung |
-
1975
- 1975-07-12 DE DE19752531204 patent/DE2531204C2/de not_active Expired
-
1976
- 1976-07-02 FR FR7620326A patent/FR2317917A1/fr active Granted
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2260189A1 (de) * | 1971-12-09 | 1973-06-20 | Hossein Ghadimi | Injizierbare aminosaeurepraeparate |
| FR2215212A1 (enrdf_load_stackoverflow) * | 1973-01-18 | 1974-08-23 | Seperic |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2935709A1 (de) * | 1978-09-04 | 1980-03-13 | Otsuka Pharma Co Ltd | Aminosaeureloesungen und deren verwendung |
| FR2711529A1 (fr) * | 1993-10-28 | 1995-05-05 | Clintec Nutrition Cy | Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme. |
| EP0655244A1 (fr) * | 1993-10-28 | 1995-05-31 | Clintec Nutrition Company | Composition à base d'acides aminés pour le traitement d'infections |
| EP1044017A4 (en) * | 1998-01-05 | 2005-01-05 | Univ Johns Hopkins | DIETETIC SUPPLEMENT FOR PATIENTS DIALYSIS |
| WO2003013487A3 (en) * | 2001-08-08 | 2003-05-30 | Professional Dietetics Srl | Amino-acid-based compositions, suitable in therapy for the healing and/or mending of wounds and lesions, in particular for application in the ophthalmic field |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2531204A1 (de) | 1977-01-13 |
| FR2317917B1 (enrdf_load_stackoverflow) | 1979-05-18 |
| DE2531204C2 (de) | 1987-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1507951A (en) | Amino acid formulations | |
| CA2177195A1 (en) | Method and composition for treating renal failure | |
| SE7907393L (sv) | Aminosyralosning for intravenos neringstillforsel | |
| GR3026072T3 (en) | Adolescent dietary composition | |
| EP0182356B2 (en) | Nutrient compositions | |
| US5034377A (en) | Aqueous nutrient compositions comprising oligopeptides | |
| CN108721596B (zh) | 一种复方氨基酸维生素注射液及其应用 | |
| Hokin | Amino-acid requirements of amylase synthesis by pigeon-pancreas slices | |
| FR2317917A1 (fr) | Melanges de l-aminoacides et leur utilisation therapeutique | |
| JPS568312A (en) | Amino acid pharmaceutical preparation | |
| IE39051L (en) | Peptides | |
| ATE88065T1 (de) | Waessrige zusammensetzung fuer die parenterale ernaehrung. | |
| JPH10506114A (ja) | 成長因子の放出を促進し得る２−アルキルトリプトファン含有ペプチド化合物 | |
| GB1460108A (en) | Pharmaceutical preparations containing aspirin or indomethacin | |
| Wretlind | The Utilization of D‐Valine for Growth in Rats | |
| ES2132021A1 (es) | Formulas de aminoacidos para personas de la tercera edad y procedimiento para el calculo de las mismas. | |
| Neuhäuser-Berthold et al. | Utilisation of N-acetyl-L-glutamine during long-term parenteral nutrition in growing rats: Significance of glutamine for weight and nitrogen balance | |
| JPS5681515A (en) | Amino acid transfusion | |
| RU2022133861A (ru) | Раствор для лечения вульвовагинальных и внутриматочных заболеваний | |
| EP1199355A4 (en) | SULFUR-FREE ENZYMS | |
| FR2365552A1 (fr) | Melange contenant des l-aminoacides essentiels et non essentiels, pour le traitement des insuffisances hepatiques | |
| Barle et al. | The effects of short‐term parenteral nutrition on human liver protein and amino acid metabolism during laparoscopic surgery | |
| CA2317038A1 (en) | Supplement for dialysis patients | |
| FR2317918A1 (fr) | Solutions d'aminoacides pour perfusion, pour prematures et enfants en bas age | |
| KR960000068B1 (ko) | 영양소 조성물의 제조방법 |